In last trading session, Viking Therapeutics Inc (NASDAQ:VKTX) saw 3.11 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price level of $71.65 trading at -$1.18 or -1.62% at ring of the bell on the day assigns it a market valuation of $7.84B. That closing price of VKTX’s stock is at a discount of -38.74% from its 52-week high price of $99.41 and is indicating a premium of 88.44% from its 52-week low price of $8.28. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.12 million shares which gives us an average trading volume of 6.53 million if we extend that period to 3-months.
Viking Therapeutics Inc (NASDAQ:VKTX) trade information
Upright in the red during last session for losing -1.62%, in the last five days VKTX remained trading in the red while hitting it’s week-highest on Thursday, 04/04/24 when the stock touched $71.65 price level, adding 10.55% to its value on the day. Viking Therapeutics Inc’s shares saw a change of 285.01% in year-to-date performance and have moved -8.66% in past 5-day. Viking Therapeutics Inc (NASDAQ:VKTX) showed a performance of 12.94% in past 30-days. Number of shares sold short was 11.14 million shares which calculate 0.93 days to cover the short interests.
Viking Therapeutics Inc (VKTX) estimates and forecasts
Statistics highlight that Viking Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 519.81% of value to its shares in past 6 months, showing an annual growth rate of -20.88% while that of industry is 13.70. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -12.00% in the current quarter and calculating -47.40% decrease in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.89% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -23.49% while estimates for its earnings growth in next 5 years are of 40.00%.
VKTX Dividends
Viking Therapeutics Inc is more likely to be releasing its next quarterly report between April 24 and April 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Viking Therapeutics Inc (NASDAQ:VKTX)’s Major holders
Insiders are in possession of 5.46% of company’s total shares while institution are holding 73.69 percent of that, with stock having share float percentage of 77.94%. Investors also watch the number of corporate investors in a company very closely, which is 73.69% institutions for Viking Therapeutics Inc that are currently holding shares of the company. FMR, LLC is the top institutional holder at VKTX for having 15.0 million shares of worth $1.08 billion. And as of Dec 30, 2023, it was holding 13.61% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 7.61 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 6.90% of outstanding shares, having a total worth of $544.96 million.
On the other hand, SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Jan 30, 2024, the former fund manager was holding 3.61 million shares of worth $258.62 million or 3.27% of the total outstanding shares. The later fund manager was in possession of 3.34 million shares on Feb 28, 2024, making its stake of worth around $239.47 million in the company or a holder of 3.03% of company’s stock.
